Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.950
-0.030 (-1.01%)
At close: Sep 3, 2025, 4:00 PM
2.920
-0.030 (-1.02%)
Pre-market: Sep 4, 2025, 8:30 AM EDT

Fortress Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
88565571249301
Upgrade
Market Cap Growth
43.33%2.43%-23.29%-71.44%-17.12%65.21%
Upgrade
Enterprise Value
83352628219243
Upgrade
Last Close Price
2.952.023.019.8237.5047.55
Upgrade
PS Ratio
1.260.970.650.943.626.59
Upgrade
PB Ratio
2.00-34.0034.391.421.101.53
Upgrade
P/TBV Ratio
6.19-24.214.902.593.51
Upgrade
EV/Sales Ratio
1.390.600.310.373.185.34
Upgrade
Debt / Equity Ratio
1.85-46.2055.822.590.330.45
Upgrade
Asset Turnover
0.390.370.370.220.190.16
Upgrade
Inventory Turnover
4.476.3110.5913.7928.5769.62
Upgrade
Quick Ratio
1.580.951.131.623.264.99
Upgrade
Current Ratio
1.921.271.381.803.435.14
Upgrade
Return on Equity (ROE)
-784.32%--597.36%-155.06%-77.95%-76.42%
Upgrade
Return on Assets (ROA)
-40.94%-41.30%-36.83%-36.84%-30.65%-21.05%
Upgrade
Return on Capital (ROIC)
-69.34%-78.27%-63.08%-52.98%-38.12%-24.87%
Upgrade
Earnings Yield
-27.40%-82.28%-111.11%-121.69%-25.98%-15.48%
Upgrade
FCF Yield
-91.24%-143.45%-235.07%-255.99%-48.62%-28.49%
Upgrade
Buyback Yield / Dilution
-87.97%-156.25%-36.89%-8.78%-13.46%-31.61%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q